Scott Daniel Cormack, President and CEO at ONCOGENEX PHARMACEUTICALS, INC. (OGXI), sold 10,000 shares at $15.99 ($80K) on 2010-11-15, disclosed to the SEC on 2010-11-17.
Scheduled sale ($80k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.99 | 5,000 | $80K | 100.0% |
| 2 | $0.00 | 5,000 | $0 | 0.0% |
| Total | $8.00 avg | 10,000 | $80K | 100% |
| Filing → |
| OGXI | SELL | 2015-06-16 | $12K | — | Filing → |
| OGXI | SELL | 2015-05-21 | $14K | — | Filing → |
| OGXI | SELL | 2014-08-14 | $58K | — | Filing → |